ETBI — Eastgate Biotech Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $5.74m
- $8.81m
Annual cashflow statement for Eastgate Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | 2016 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.623 | -1.72 | -4.91 | -4.28 | -2.98 |
| Depreciation | |||||
| Non-Cash Items | 0.393 | 0.082 | 1.43 | 1.01 | 0.985 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.23 | 1.22 | 2.21 | 2.66 | 1.6 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 0 | -0.408 | -1.24 | -0.568 | -0.389 |
| Capital Expenditures | — | -0.022 | -0.1 | 0 | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | -0.022 | -0.1 | 0 | — |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.1 | 0.33 | 1.63 | 0.327 | 0.322 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.1 | -0.1 | 0.286 | -0.267 | -0.019 |